ANNOUNCEMENT 01 Oct 2011

In October 2011, the government of Pakistan initiated a new anti-dumping investigation.

NUMBER OF INTERVENTIONS

1

  • 0 harmful
  • 1 neutral
  • 0 liberalising

SOURCE



WTO semi-annual report on antidumping. Document: G/ADP/N/237/PAK
WTO, Committee on Anti-Dumping Practices, Semi-annual Report under Article 16.4, Pakistan, 28.02.2014 (Document G/ADP/N/252/PAK):
https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S006.aspx?Query=(%40Symbol%3d+g%2fadp%2fn*+and+%40Title%3d+report*+and+semi*+)+and+(+%40DocumentDate+%3e%3d+2014%2f01%2f01+00%3a00%3a00+)+and+(+%40DocumentDate+%3c%3d+2014%2f12%2f31+23%3a59%3a59+)&Language=ENGLISH&Context=FomerScriptedSearch&languageUIChanged=true#

Government of Pakistan, National Tariff Commission, ADC No. 29/2012/NTC/PIA of 17 January 2015: http://ntc.gov.pk/wp-content/uploads/2016/05/060215-Notice-of-Conclusion-16-01-15.pdf


Inception date: No inception date

Anti-dumping

On December 14, 2012, the Pakistani authorities initiated an anti-dumping investigation on imports of pegylated interferon alpha-2A from Switzerland.
The products subject to investigation are classified under the following HS code: 3002.2090. The dumping is suspected to have occurred between October 1, 2011 and September 30, 2012.
 
On July 27, 2013, the Pakistani authorities made a preliminary determination of dumping. The dumping margin is 27.58%. However, no provisional duty was imposed.
The Sindh High Court has granted stay in this investigation.
 
On 17 January 2015, theNational Tariff Commission concluded the above investigation without the imposition of duties.

AFFECTED SECTORS

 

AFFECTED PRODUCTS